Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte  by Gardai, Shyra J. et al.
Cell, Vol. 123, 321–334, October 21, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.cell.2005.08.032
Cell-Surface Calreticulin Initiates Clearance
of Viable or Apoptotic Cells through
trans-Activation of LRP on the Phagocyte
Shyra J. Gardai,1,3 Kathleen A. McPhillips,2
S. Courtney Frasch,1 William J. Janssen,3
Anna Starefeldt,5 Joanne E. Murphy-Ullrich,6
Donna L. Bratton,1 Per-Arne Oldenborg,5
Marek Michalak,4 and Peter M. Henson1,*
1Program in Cell Biology
Department of Pediatrics
National Jewish Medical and Research Center
1400 Jackson St.
Denver, Colorado 80206
2Department of Pathology
3Department of Medicine
Division of Pulmonary Science and Critical Care
Medicine
University of Colorado Health Sciences Center
4200 E. 9th Avenue
Denver, Colorado 80262
4Membrane Protein Research Group
Department of Biochemistry
University of Alberta
Edmonton, Alberta T6G 2H7
Canada
5Department of Integrative Medical Biology
Section for Histology and Cell Biology
Umeå University
Umeå SE-90187
Sweden
6Department of Pathology
Division of Molecular and Cellular Pathology and
The Cell Adhesion and Matrix Research Center
University of Alabama at Birmingham
Birmingham, Alabama 35294
Summary
Apoptotic-cell removal is critical for development, tis-
sue homeostasis, and resolution of inflammation.
Although many candidate systems exist, only phos-
phatidylserine has been identified as a general rec-
ognition ligand on apoptotic cells. We demonstrate
here that calreticulin acts as a second general rec-
ognition ligand by binding and activating LDL-recep-
tor-related protein (LRP) on the engulfing cell. Since
surface calreticulin is also found on viable cells, a
mechanism preventing inadvertent uptake was sought.
Disruption of interactions between CD47 (integrin-
associated protein) on the target cell and SIRP
(SHPS-1), a heavily glycosylated transmembrane pro-
tein on the engulfing cell, permitted uptake of viable
cells in a calreticulin/LRP-dependent manner. On
apoptotic cells, CD47 was altered and/or lost and no
longer activated SIRP. These changes on the apo-
ptotic cell create an environment where “don’t eat
me” signals are rendered inactive and “eat me” sig-
nals, including calreticulin and phosphatidylserine,
congregate together and signal for removal.*Correspondence: hensonp@njc.orgIntroduction
Removal of apoptotic cells in multicellular organisms is
critical for development, tissue remodeling, maintenance
of homeostasis, and response to injury. Rapid and effi-
cient apoptotic-cell clearance is crucial to prevent cell ly-
sis and the release of proinflammatory and antigenic
autoimmune components. Clearance of apoptotic cells
appears to occur by highly conserved mechanisms and
specific signaling pathways (Hoffmann et al., 2001; Og-
den et al., 2001). The uniqueness of this process has led
us to suggest the name efferocytosis (from effero—to
carry to the grave, to bury) (deCathelineau and Henson,
2003). Many different cell types are capable of effero-
cytosis, including both professional (macrophages or
immature dendritic cells) and so-called nonprofessional
phagocytes (fibroblasts and endothelial and epithelial
cells). Apoptotic-cell removal in vivo usually occurs in
situ by near neighbors and generally without induction
of a local tissue response.
A wide variety of phagocyte (efferocyte) cell-surface
receptors and soluble bridging molecules have been
implicated in recognition and removal of apoptotic cells
(Savill et al., 2002). Surprisingly, much less is known
about the apoptotic-cell-surface structures that are be-
ing recognized. We earlier showed that they expose
phosphatidylserine (PS) and that this was involved in
their removal, as well as in the induction of anti-inflam-
matory and anti-immunogenic responses (Fadok et al.,
2001a; Hoffmann et al., 2005). Although other surface
changes have been implicated in apoptotic-cell rec-
ognition (see Dini, 2000; Moffatt et al., 1999), no other
ligand with such a wide distribution between cell types
and across animal phyla has yet been identified.
Calreticulin is a highly conserved, 46 kDa protein
earlier considered to be an obligate endoplasmic retic-
ulum protein. The localization of calreticulin within the
cell is broad and is still not completely clear. It is found
in the ER/SR membranes (Ostwald and MacLennan,
1974) and seems to localize to the nucleus (Burns et
al., 1994). It is also found on the surface of most mam-
malian cells (Arosa et al., 1999; Sadasivan et al., 1996;
White et al., 1995) and was earlier shown to be identical
to a key cellular receptor for C1q (Stuart et al., 1997).
Cellular stress, including apoptosis, induces expres-
sion of many stress proteins, including calreticulin (Heal
and McGivan, 1998); this may lead to increased
amounts of calreticulin on the cell surface (Jethmalani
et al., 1997), although how calreticulin gets there is not
fully understood. It may remain associated with pro-
teins that it chaperones, such as MHC class 1, or, alter-
natively, its KDEL retrieval sequence may be cleaved
(Arosa et al., 1999).
In the ER, calreticulin participates in calcium homeo-
stasis and acts as a protein chaperone (Krause and
Michalak, 1997; Sadasivan et al., 1996). On the cell sur-
face, it binds thrombospondin and induces focal adhe-
sion disassembly (Orr et al., 2003a). This effect is medi-
ated through the LDL-receptor-related protein (LRP,
also known as CD91 or the α2-macroglobulin receptor)
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322(Orr et al., 2003b). Our own previous studies have impli-
cated calreticulin in apoptotic-cell removal, as it can
act as a “receptor,” in conjunction with LRP, on the ef-
ferocyte for the collagenous tails of collectin family
members (Ogden et al., 2001; Vandivier et al., 2002).
These ligands for calreticulin can stimulate cells through
a cis interaction with LRP on the same responding cell.
However, the wide distribution of calreticulin on cell
surfaces also raised the possibility that this molecule
on apoptotic cells could directly bind and stimulate
LRP on a responding cell, i.e., acting in trans mode.
Accordingly, the potential for calreticulin to serve as an-
other general ligand for recognition and clearance of
apoptotic cells is addressed and supported by the data
reported herein.
Calreticulin is found on the surface of viable cells;
why then does it not induce their uptake? We provide
evidence that surface calreticulin is increased and re-
distributed during apoptosis, possibly enhancing stim-
ulation of LRP on the efferocyte. In addition, the pro-
cess of apoptosis is shown to induce alterations of
active regulatory signals present on viable cells that
normally prevent their removal.
CD47 (integrin-associated protein, IAP), is widely dis-
tributed on cells and binds to a number of proteins
(Brown and Frazier, 2001; Cant and Ullrich, 2001), in-
cluding SIRPα, a heavily glycosylated transmembrane
protein with an immunoreceptor tyrosine-based inhibi-
tion motif (ITIM) domain. Ligation of SIRPα leads to ty-
rosine phosphorylation (Kharitonenkov et al., 1997) and
subsequent activation of inhibitory tyrosine phospha-
tases such as SHP-1 and SHP-2. Interaction of CD47
with SIRPα blocks IgG or complement-induced phago-
cytosis (Oldenborg et al., 2001). Moreover, nonopson-
ized erythrocytes from CD47−/− mice are recognized
and rapidly eliminated in wild-type recipients and are
phagocytosed by wild-type macrophages in vitro (Old-
enborg et al., 2000). For these reasons, we examined
the possible role for the CD47-SIRPα system in pre-
venting uptake of calreticulin-expressing viable cells
and for its likely inactivation during apoptosis to allow
removal of apoptotic cells.
Results
Calreticulin (CRT) on Apoptotic Cells
Is a Ligand for Their Removal
Pretreatment of apoptotic fibroblasts, neutrophils, or
Jurkat T cells with a blocking antibody against calretic-
ulin (followed by washing) reduced their ingestion (Fig-
ure 1A). Fibroblasts were used as phagocytic cells to
extend the observations to nonprofessional phago-
cytes as well as to avoid Fc receptor (FcR) effects. Fur-
thermore, apoptotic CRT-deficient mouse embryonic
fibroblasts (MEFs) were not engulfed by either macro-
phages or fibroblasts (Figure 1B). Since these cells un-
derwent apoptosis to the same degree as wild-type
(Figure 1C) and showed no changes in PS exposure
(see below and see also Figure S2 in the Supplemental
Data available with this article online), the difference in
uptake can be attributed to the absence of calreticulin.
Direct addition of exogenous calreticulin to either viable
or apoptotic CRT−/− MEFs restored surface calreticulin
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cevels to those observed on wild-type cells (Figure 1D)
nd restored the ability of apoptotic cells to be ingested
y murine thioglycollate-elicited peritoneal macrophages,
uman monocyte-derived macrophages (HMDMs), and
onprofessional phagocytes (Figure 1E and Figure S1).
he presence of a calreticulin-expressing cell could not
tself passively restore staining on CRT-deficient MEFs
Figure S3). Heat shock protein 90 (Hsp90), another li-
and for LRP, was used as a control and was shown to
e ineffective. Additionally, factor Va blocking of PS on
ild-type or CRT−/− MEFs reconstituted with calretic-
lin reduced efferocytosis of both cell types (data not
hown), showing normal activity of the PS system.
A role for calreticulin in apoptotic-cell clearance in vivo
as supported by examination of 13.5 day embryos from
RT−/− mice (the deletion is embryonic lethal; Mesaeli et
l., 1999). In the wild-type and heterozygote embryos,
poptotic cells (stained for active caspase 3) were
bserved predominantly within macrophages (F4-80
ositive) (Figure 1F), whereas increased numbers of non-
ngested apoptotic cells were observed in the CRT−/− em-
ryos (Figure 1G). In addition, apoptotic wild-type and
RT−/− MEFs were injected into the peritoneum of nor-
al mice. Lavage after 1 hr showed that CRT−/− MEFs
ere not cleared as efficiently as controls (Figure 1H
nd Figure S4).
irect Stimulation with Calreticulin Induces
acropinocytosis and Efferocytosis through LRP
hree additional lines of evidence support direct stimu-
ation of engulfing cells by exogenous calreticulin. First,
alreticulin induces macropinocytosis (Figure 2A), a
rocess related to efferocytosis (Hoffmann et al., 2001).
sp90 was ineffective. Second, bystander uptake (Hoff-
ann et al., 2001; Ogden et al., 2001) was directly stim-
lated by soluble calreticulin (Figures 2B and 2C). This
as accompanied by the incorporation of lucifer yel-
ow, a water-soluble dye used to measure extracellular
luid internalization and indicating formation of spa-
ious phagosomes. Third, in keeping with the known
equirement for Rac-1 in mammalian and nematode
poptotic-cell uptake, exogenous calreticulin directly
nduced activation of Rac-1 in J774 macrophages (Fig-
re S5). In further support of the role for calreticulin,
poptotic CRT−/− MEFs reconstituted with exogenously
dded calreticulin were now able to stimulate mem-
rane ruffling and macropinocytosis in macrophages
Figure 2D and Movies S1 and S2).
Cell-surface calreticulin is known to bind and form
omplexes with LRP on that same surface, i.e., to act
n a cis mode (Orr et al., 2003b). This made phagocyte
RP the prime candidate also for this trans-stimulation
y calreticulin on the apoptotic cell. Thus, a ligand-
locking antibody against LRP was found to substan-
ially reduce apoptotic-cell uptake (to the levels ob-
erved with CRT−/− targets) (Figure 2E). An antibody
gainst the intracellular domain of LRP (which did not
lter LRP activity) or an irrelevant surface protein, CD45,
ad no effect. To determine if exogenous calreticulin di-
ectly interacted with LRP, wild-type and LRP−/− MEFs
ere examined for binding of exogenous calreticulin by
low cytometry (Figure 2F). In contrast to wild-type
ells, not only did LRP−/− MEFs show reduced calretic-
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323Figure 1. Calreticulin on Apoptotic Cells Is Required for Their Engulfment
Error bars are ±SD. *p < 0.05 versus control.
(A) Blockade of surface calreticulin on apoptotic Jurkat T cells, human neutrophils, or murine MEFs with anti-CRT antibody inhibited uptake
into MEFs without affecting their viability or the viability of the phagocyte.
(B) Engulfment of apoptotic CRT−/− MEFs by J774 macrophages or fibroblasts was significantly decreased in comparison with uptake of wild-
type MEF cells.
(C) Demonstration of comparable apoptosis in CRT−/− or wild-type. Apoptosis was assessed with a Phi-Phi Lux reagent and analyzed for
peptide cleavage by flow cytometry.
(D) Calreticulin can be reconstituted on the surface of CRT−/− MEFs. Wild-type and CRT−/− MEFs were stained for calreticulin after pretreat-
ment (followed by washing) with exogenously added calreticulin. Isotype control is of apoptotic wild-type MEFs and is representative of
all samples.
(E) Reconstitution of calreticulin on the CRT−/− cells restored their ability to be ingested. Apoptotic wild-type and CRT−/− cells were coated
with either calreticulin or Hsp90 and assessed for uptake into murine thioglycollate-elicited macrophages or human monocyte-derived macro-
phages (HMDMs).
(F) CRT-deficient embryos exhibit decreased numbers of apoptotic cells associated with macrophages. Day 13.5 embryos were sectioned
and stained for active caspase 3 (red) or a macrophage cell marker F4-80 (green) and DAPI (blue) and were analyzed for interactions.
(G) Apoptotic bodies in wild-type and calreticulin heterozygote and knockout embryos were quantified.
(H) Apoptotic CRT−/− or wild-type MEFs were instilled into the murine peritoneum for 60 min. After 60 min, lavagates were assessed for phago-
cytosis.ulin on their surface at baseline, but upon addition of
calreticulin there was no enhancement of surface
levels.
Receptor-associated protein (RAP) has been used
extensively as an antagonist in the study of LRP and
blocks LRP signaling to a large variety of ligands (Bu,
2001; Obermoeller-McCormick et al., 2001; Orr et al.,
2003a). RAP inhibited the engulfment of CRT−/− MEFs
reconstituted with calreticulin to the same degree asseen with anti-LRP antibody (Figure 2G). This indicated
that calreticulin on target cells binds directly to macro-
phage LRP. To further support direct interaction of cal-
reticulin and LRP, pretreatment of macrophages with
RAP inhibited calreticulin-induced macropinocytosis
(Figure 2H) and activation of Rac-1 (Figure S5). Impor-
tantly, LRP−/− MEFs stimulated with calreticulin were
unable to undergo macropinocytosis (Figure S6). LRP−/−
MEFs were inefficient at ingesting apoptotic cells and
Cell
324Figure 2. Direct Addition of Calreticulin Stimulates Macrophage Ruffling, Macropinocytosis, and Bystander Uptake
Error bars are ±SD.
(A) Macropinocytosis: macrophages were stimulated with calreticulin or Hsp90 as a control in the presence of lucifer yellow (LY) for 20 min.
Nuclei are shown in blue (DAPI) and LY uptake in green.
(B) Stimulation with soluble calreticulin initiates engulfment of viable neutrophils preadhered to J774 macrophages (see Experimental Pro-
cedures).
(C) Bystander uptake of preadhered viable Jurkat T cells into macrophages stimulated with soluble calreticulin involves engulfment into
spacious phagosomes with accompanying LY. The Jurkat T cells are red (cell tracker red), and LY is shown in green.
(D) Calreticulin on the surface of target cells promotes ruffling, macropinocytosis, and engulfment in macrophages. Apoptotic CRT−/− MEFs
alone or reconstituted with calreticulin were incubated with J774 macrophages, and live images were captured (see also Movies S1 and S2).
Shown are representative 15 s frames from a 30 min movie. Black arrows identify J774 macrophages; white arrows identify the apoptotic
MEFs.
(E) Ingestion was inhibited with a blocking anti-LRP antibody. Macrophages were treated with antibodies against either the intra- or extracellu-
lar domains of LRP as well as the irrelevant surface protein CD45 for 30 min before examination of apoptotic-cell uptake.
(F) Wild-type and LRP−/− MEFs were analyzed for surface calreticulin expression by flow cytometry in either the presence or absence of
calreticulin. Isotype controls were identical; the one shown is for apoptotic wild-type MEFs and is representative of all isotypes performed.
(G) Preincubation of J774 macrophages with RAP, an inhibitor of LRP, or the LRP-blocking antibody inhibited engulfment of apoptotic CRT−/−
MEFs reconstituted with calreticulin. Percent inhibition of RAP and anti-LRP for calreticulin-coated wild-type MEFs was 65 ± 5.8 and 63.3 ±
4, respectively. This was similar to 76% ± 5% and 76% ± 6% for the CRT−/− MEFs.
(H) Addition of RAP prevented calreticulin-induced macropinocytosis. J774 macrophages pretreated with RAP were stimulated with calretic-
ulin in the presence of lucifer yellow (green) before fixation and processing for ingested LY, nuclei (blue).
(I) Treatment of macrophages with calreticulin reduced surface antibody staining for RAP. HMDMs stimulated in the presence or absence of
calreticulin and then stained with anti-RAP antibody were examined by FACS. In reverse, treatment of HMDMs with RAP reduced staining for
surface calreticulin. Isotypes presented are HMDMs treated with calreticulin or RAP, respectively, and were equivalent for all samples.therefore could not be used as phagocytes in these ex-
periments.
The mechanisms by which calreticulin activates LRP
are unknown. In the cis mode, thrombospondin was
suggested to induce calreticulin-LRP association (Orr
g
t
p
w
ret al., 2003b). On the other hand, in keeping with a sug-estion by Li et al. (2000), we hypothesized that calre-
iculin may stimulate LRP by displacing normally sup-
ressive RAP. To examine this possibility, macrophages
ere stained for surface RAP after incubation with cal-
eticulin. Addition of calreticulin significantly reduced
the amount of surface RAP, and, reciprocally, RAP re-
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325duced the levels of calreticulin (Figure 2I), supporting a
competitive effect on LRP binding sites. In addition,
only the full-length form of calreticulin and a mutant
form lacking the thrombospondin binding domain re-
duced the amount of surface RAP (Figure S8). A frag-
ment of calreticulin containing only the thrombospon-
din binding region had no effect on RAP levels and was
unable to restore engulfment of CRT−/− MEFs (Figure
S7). While these experiments support direct stimulation
of efferocyte LRP by calreticulin, we also questioned
the possible contribution of thrombospondin. This has
been suggested to participate in apoptotic-cell clear-
ance (Savill et al., 1992) and is known to ligate calretic-
ulin to stimulate LRP in a cis mode on the same re-
sponding cell (Orr et al., 2003b). Importantly, CRT−/−
MEFs reconstituted with calreticulin or mutated forms
lacking the thrombospondin binding domain restored
uptake into macrophages. However, a peptide fragment
of calreticulin containing only the thrombospondin
binding domain had no effect (Figure S7).
Calreticulin Distribution on Apoptotic Cells
A potential problem with this model is that calreticulin
is found on the surface of most cells, whether or not
they are apoptotic, without stimulating uptake. To ex-
plain the selective recognition and effect of calreticulin
on apoptotic versus viable cells, we suggest alterations
in the amount and distribution of calreticulin during
apoptosis as well as alterations in “don’t eat me” sig-
nals that normally prevent uptake of viable cells. Exami-
nation of a variety of cell types with different apoptosis
inducers showed that the overall amounts of calreti-
culin on the cell surface increased during apoptosis
(shown for fibroblasts and Jurkat T cells in Figure 3A).
Intriguingly, for both cell types, a subpopulation showed
a high-intensity staining with anti-calreticulin. This did
not correlate exactly with the proportion that was apo-
ptotic at that time point or with membrane permeability.
Less than 5% were propidium iodide permeable, and
these showed only low-intensity staining for calreticulin
(data not shown). The potential relationship between
increased calreticulin exposure and the degree of apo-
ptosis is shown for neutrophils in Figure 3B. Surface
calreticulin increased as cells became more apoptotic
(Figure 3B), and this correlated with decreased CD47
levels (Figure S10) and an increased ability to become
engulfed (phagocytic indexes were 3, 6, 10, and 15, re-
spectively). Additionally, surface calreticulin became
markedly redistributed into patches on the cell surface
of apoptotic neutrophils (Figure 3C), a phenomenon
seen for all cells so far studied and that may contribute
to calreticulin’s ability to stimulate LRP on the effero-
cyte. Furthermore, exogenous calreticulin on the sur-
face of apoptotic CRT−/− cells was seen in patches, but
less so if they were viable (Figure 3D). At this point, we
cannot rule out a possible change in calreticulin struc-
ture or exposure on the apoptotic cell that may make it
a more effective LRP stimulus.
Ingestion of Viable Cells in the Absence
of CD47-SIRP “Don’t Eat Me” Stimulation
An additional explanation for calreticulin (or indeed
other ligand) gain of function could be that apoptotic
cells lose normally inhibitory signals that inhibit calre-ticulin-LRP stimulation. A likely candidate is CD47 on
the target interacting with SIRPα on the efferocyte. As
shown in Figure 4A, viable CD47−/− erythrocytes or leu-
kocytes were readily taken up into macrophages and
nonprofessional phagocytes by processes similar to
apoptotic-cell removal. Leukocytes were engulfed into
spacious phagosomes with accompanying extracellu-
lar fluid (Figure 4B), and engulfment of erythrocytes
was blocked by amiloride (Figure S9), which inhibits
macropinocytosis and efferocytosis but not FcR-medi-
ated phagocytosis (deCathelineau and Henson, 2003;
Hoffmann et al., 2001). In addition, inhibition of CD47
on target cells with a Fab#2 antibody and blockade of
SIRPα on the engulfing cell each led to uptake of viable
human neutrophils (Figures 4C and 4D). Engulfed cells
were identified as viable by maintenance of normal
nuclear architecture and lack of activated caspase 3
(Figures 4E and 4F). Accompanying this uptake in-
duced by blockade of CD47-SIRPα “don’t eat me” sig-
nals was extensive induction of membrane ruffling
(Movies S3 and S4).
The uptake appeared dependent on LRP and calretic-
ulin since CD47−/− erythrocytes incubated with LRP−/−
MEFs were not ingested, compared to wild-type MEFs
(Figure 5A). By plating macrophages on surfaces
coated with anti-LRP antibody to “modulate” the LRP
beneath the engulfing cells and away from the targets,
suppression of uptake was again observed (Figure 5B).
This treatment does not suppress uptake through the
Fc receptor (Ogden et al., 2001). Similar data were ob-
tained with viable CD47−/− leukocytes as targets (data
not shown). Additionally, antibody blockade of calretic-
ulin on the CD47−/− target cells as well as inhibition of
macrophages with RAP prevented uptake to the same
degree (Figure 5C). Importantly, blockade or absence
of CD47 did not alter PS exposure (Figure 5D), i.e., PS
and its recognition processes did not appear to be re-
quired.
Redistribution of Calreticulin and PS Away
from CD47 on the Apoptotic-Cell Surface
CD47 is present on most cells and must presumably be
removed or inactivated during apoptosis to allow their
remarkably efficient clearance. Examination of a variety
of apoptotic-cell types (e.g., neutrophils and fibro-
blasts) revealed an overall decrease in detectable CD47
(Figures 6A and 6B) that correlate with the degree of
apoptosis (Figure S10). By contrast, murine lympho-
cytes or human Jurkat T cells did not show a decrease
in CD47 (Figure 6C) but rather an increase in surface
patching during apoptosis (Figure 6D). Patching oc-
curred on other apoptotic-cell types whether or not the
total surface levels were reduced, and, most impor-
tantly, the CD47 became segregated away from calre-
ticulin (Figure 6E and data not shown).
Redistribution of surface CD47 could reduce its over-
all ability to bind SIRPα on the efferocyte. However, we
did not find a significant difference in binding of a solu-
ble SIRPα-Fc construct to viable or apoptotic Jurkat T
cells or neutrophils (data not shown). On the other
hand, stimulation of the SIRPα by CD47 on the apo-
ptotic cell was altered. Viable but not apoptotic Jurkat
T cells induced macrophage SIRPα phosphorylation to
levels seen following direct addition of a CD47-Fc li-
Cell
326Figure 3. Calreticulin Is Upregulated and Redistributed on Apoptotic Cells
(A) Surface expression of calreticulin was increased on apoptotic fibroblasts and Jurkat T cells as measured by FACS analysis with an
anti-calreticulin antibody. PI-positive cells were excluded (5%). The isotype control is of apoptotic fibroblasts and is representative of all
isotype samples.
(B) Neutrophils were induced to undergo apoptosis for various times and calreticulin levels assessed by flow cytometry. Apoptosis at the
various time points was 5%, 18%, 31%, 52%, and 67%. Isotype control represents neutrophils undergoing apoptosis for 120 min.
(C) The pattern of calreticulin staining changes as cells undergo apoptosis, becoming distinctly more patched. Viable and apoptotic neutro-
phils were stained with an anti-calreticulin antibody, fixed, and examined. Calreticulin staining is shown is red and nuclei in blue.
(D) Exogenous addition of calreticulin to CRT−/− MEFs also displayed the patched surface staining changes on CRT−/− MEFs as they be-
came apoptotic.gand even though the CD47 on the latter was not re-
duced in total amount (Figure 6F). Viable neutrophils
also induced SIRPα phosphorylation (Figure 6F). The
target cells did not contribute any phosphorylated
SIRPα (data not shown). SIRPα acts through stimula-
tion of the tyrosine phosphatases SHP-1 and 2, and its
activation of SHP-1 can inhibit Fc-mediated phagocy-
tosis (Okazawa et al., 2005). Accordingly, pretreatment
of macrophages with a SHP-1 inhibitor promoted up-
take of viable neutrophils, while a control SHP-2 inhibi-
tor had little effect (Figure 6G). Furthermore, stimulation
of SIRPα with the soluble CD47-Fc blocked apoptotic-
cell uptake (Figure 6H).
Calreticulin Associates with PS on Apoptotic Cells
The redistributed CD47 segregated away from calretic-
ulin on the apoptotic cell (Figure 6E), suggesting a sep-
aration of “don’t eat me” signaling from those inducing
uptake. Apoptotic wild-type and CRT−/− MEFs were
shown to expose PS to comparable degrees (Figure
7A). Examination of the apoptotic-cell surfaces, as
shown in Figure 7B, demonstrated that a significant
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croportion of the two “eat me” ligands, PS and calretic-
lin, were found together in patches on the apoptotic-
ell membrane and therefore away from CD47. Addi-
ionally, apoptotic cells that exposed PS displayed
igher levels of calreticulin (Figure S11). PS and calre-
iculin also colocalized with markers for cholesterol-
ich, GM-1 ganglioside-containing “rafts” (Figure 7C).
hus, the “don’t eat me” CD47 became excluded from
he “eat me” calreticulin and PS domains on the apo-
totic cell (Figure S12). CD47 has also been reported
o reside within cholesterol-rich domains. Thus, its seg-
egation away from GM-1-, PS-, and calreticulin-con-
aining regions suggests either its loss from such do-
ains or its association with cholesterol-rich regions
ontaining different glycosphingolipids. At this point,
either the structures on the cell to which endogenous
r exogenous calreticulin is binding nor the mechanism
or its exposure is known. Nevertheless, our data sup-
ort a model in which PS becomes exposed in choles-
erol-rich domains (Frasch et al., 2004) along with cal-
eticulin and, together with calreticulin, provides
ooperative stimuli for engulfment.
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the “eat me” PS and calreticulin signals and “don't eat
me” CD47, the human monomyelocytic PLB-985 cell
line was employed. Undifferentiated, these cells un-
dergo normal apoptosis but do not expose PS, whereas
after differentiation they recover this ability (Fadok et
al., 2001b). Uptake of undifferentiated apoptotic PLB-
985 cells is decreased compared to differentiated, PS-
exposing cells, supporting the role of PS in engulfment
(Fadok et al., 2001b). Undifferentiated PLB-985 cells do
exhibit surface calreticulin, which is both upregulated
and redistributed during apoptosis (Figure 7E). This
might indicate a primary role for PS in stimulating effer-
ocytosis. However, the apoptotic undifferentiated PLB-
985 cells neither downregulated nor redistributed their
surface CD47 (Figure 7F), and, if cells were pretreated
with blocking anti-CD47 Fab#2 antibody, they were now
readily ingested (Figure 7D), even though they were still
deficient in PS exposure. Blockade of calreticulin also
prevented uptake (data not shown). As expected, the
differentiated apoptotic PLB-985 cells were ingested
and not only exposed PS in a normal fashion but also
exhibited decreased levels and redistribution of CD47
(Figure 7F and Figure S13). These observations support
a key role for calreticulin in efferocytosis and also raise
the intriguing question of a relationship between PS ex-
posure and the loss or patching of CD47 (Figure 7G).
Discussion
Identifying the ligands on apoptotic cells that are in-
volved in their recognition and engulfment has proven
challenging. The data presented herein demonstrate
that, in addition to phosphatidylserine, calreticulin
serves as a crucial recognition and clearance ligand on
apoptotic cells. It appears to mediate engulfment of
apoptotic cells by activating the internalization recep-
tor, LRP, on the phagocyte. Increasingly, LRP fits the
role of a key signaling receptor for efferocytosis. It is
highly conserved; the LRP homolog in Drosophila has
also been implicated in apoptotic-cell clearance (Man-
aka et al., 2004), and the intracellular domains of mam-
malian LRP and C. elegans CED1 can be exchanged
(Su et al., 2002). Not surprisingly, deletion of LRP or
calreticulin in mice disrupts development and is lethal.
We show that calreticulin activation of LRP stimulates
Rac-1 and drives engulfment (efferocytosis) of apo-
ptotic cells.
The experiments also suggest that calreticulin does
not need to be bound by a ligand (such as thrombo-
spondin or collectins) to engage and stimulate LRP.
Rather, we suggest (see also Li et al., 2000) that the
observed displacement of RAP from the LRP by calre-
ticulin may lead to release of the LRP from a RAP-
induced latent or inhibited state.
The role for surface calreticulin in recognition of
apoptotic cells is supported by its upregulation and re-
distribution during apoptosis prior to postapoptotic
membrane permeability. A wide variety of professional
and nonprofessional phagocytes were unable to ingest
CRT−/− cells unless calreticulin was restored on their
surface. It is not at this point clear what structures the
calreticulin binds to on either viable or apoptotic cells.Although not explored rigorously, restoration of calre-
ticulin on apoptotic cells appeared to be saturated (Fig-
ure 1D), implying limited availability of binding sties.
More calreticulin bound to apoptotic versus viable
CRT−/− cells and, in the former, in distinct patches. The
segregation of calreticulin into GM-1-positive areas in-
dicates that the binding partner may redistribute into
rafts.
In addition, the sites of calreticulin exposure or bind-
ing significantly, but not exclusively, corresponded with
localized areas of PS exposure, supporting a combined
role for each in optimal apoptotic-cell recognition and
induction of uptake. It seems likely that calreticulin
alone can stimulate uptake of apoptotic cells but, in
normal circumstances, PS and calreticulin act together
to drive optimal efferocytosis. On the other hand, PS
appears to drive the anti-inflammatory consequences
of apoptotic-cell recognition, whereas LRP stimulation
is, if anything, proinflammatory (Gardai et al., 2003). We
suggest a balance between these secondary effects,
with the PS anti-inflammatory response usually dom-
inant.
Apoptotic cells have been noted in CRT−/− embryos
(Rauch et al., 2000) and herein. Clearance in vivo is usu-
ally highly efficient, and detection of free apoptotic cells
may be evidence for a greatly increased rate of apopto-
sis or, more likely, clearance defects. These two possi-
bilities cannot be distinguished in the CRT−/− mice, and
loss of multifunctional calreticulin might increase apopto-
sis as well as decrease clearance (although CRT−/−
MEFs can be cultured and do not show increased apo-
ptosis in vitro; Figure 1C and Rauch et al., 2000). To
further support a role for calreticulin in vivo, clearance
of CRT−/− MEFs in the peritoneum of a normal mouse
was found to be defective compared to wild-type
control.
Calreticulin is also found on the surface of most via-
ble cells examined, including erythrocytes (data not
shown). Accordingly, if it is a key ligand for apoptotic-
cell recognition, its apparent inactivity on such viable
cells needs explanation. Upregulation and patching of
calreticulin during apoptosis may enhance its effects
but are unlikely to be the complete explanation. On the
other hand, removal and/or inactivation of “don’t eat
me” signals during apoptosis could allow calreticulin
and other ligands to now induce their uptake. We show
here that direct activation of SIRPα with CD47 inhibits
efferocytosis of apoptotic cells and that viable cells ex-
pressing normal amounts and distribution of CD47
stimulate SIRPα phosphorylation in the phagocytes
and are not ingested. By contrast, apoptotic cells lose
their ability to activate SIRPα and are engulfed. The
mechanisms for the observed loss, redistribution, and
inactivation have not been elucidated. However, the
CD47 did become redistributed into patches that were
segregated away from the calreticulin and PS “eat me”
stimuli. In addition, many cell types (though not all) did
show decreased staining for CD47 after they became
apoptotic.
In contrast, Tada et al. (2003) proposed that CD47 is
required for removal of apoptotic cells, although with a
limited spectrum of phagocytic cells. A possible expla-
nation is that bridging molecules found in plasma can
use CD47 to tether apoptotic cells to phagocytes via
Cell
328Figure 4. CD47 Is a Potent “Don’t Eat Me” Signal on Viable Cells
Error bars are ±SD. *p < 0.05 versus control.
(A) Viable leukocytes and RBCs lacking CD47 are ingested by macrophages. Wild-type or CD47−/− leukocytes or RBCs isolated from whole
blood were incubated with J774 macrophages and examined for uptake.
(B) Engulfment of CD47−/− RBCs and leukocytes incubated with J774 macrophages was accompanied by concurrent ingestion of lucifer
yellow, indicating the formation of spacious phagosomes. J774 macrophage nuclei are stained blue (DAPI); the lucifer yellow, green; F-actin,
red. The cell engulfed in the J774 macrophage is a viable mouse neutrophil. The white arrow on the DIC points to a CD47−/− RBC within the
phagosome of a J774 macrophage.
(C and D) Blockade of CD47 on the target cells (C) or of SIRPα on the macrophages (D) resulted in viable-cell engulfment. Viable human
neutrophils were treated with an anti-CD47 Fab#2 antibody or an isotype control and incubated with J774 macrophages followed by washing
before addition to the macrophages. Alternatively, the macrophages were incubated with an anti-SIRPα antibody or an isotype control prior
to the addition of viable neutrophils.
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329Figure 5. When CD47 or SIRPα Is Absent or Inactivated, Calreticulin on the Viable Cell Interacting with LRP on the Efferocyte Induces En-
gulfment
Error bars are ±SD. *p < 0.05 versus control; #p < 0.05 versus experimental sample.
(A) LRP−/− MEFs were unable to ingest CD47−/− RBCs.
(B) Sequestration of LRP beneath the macrophages by plating them on anti-LRP antibody prevented uptake of CD47−/− RBCs.
(C) Blocking calreticulin on CD47−/− RBCs by preincubation with anti-CRT antibody and addition of RAP to block LRP on the macrophages
each prevented engulfment of the RBCs.
(D) To exclude a possible involvement of phosphatidylserine in uptake of CD47-inhibited viable cells, blocking Fab#2 anti-CD47 (which induces
uptake) was shown not to induce exposure of PS on viable neutrophils, i.e., staining with annexin V was negative.cytes (i.e., with no CD47 at all) were not engulfed as
(E) Demonstration of viable-cell uptake. J774 macrophages were pretreated with anti-SIRPα for 20 min prior to the addition of viable or
apoptotic neutrophils or were incubated with apoptotic neutrophils without pretreatment. Samples were stained for anti-active caspase 3
(red) and DAPI (blue) to show uptake of cells with intact nuclei and lacking active caspase 3.
(F) To show complete uptake of viable cells, confocal sections were taken in series through the macrophages in 1 m intervals. Panels are
arranged from the upper cell surface to the bottom. Black arrows indicate viable neutrophil nuclei.
absence of CD47 had no effect on phagocytosis (A.S.their secondary bridging to CD36 or αv integrins. In the
presence of serum, apoptotic CD47-deficient leuko-well as CD47-expressing cells. However, in the absence
of serum, although ingestion was less, the presence or
Cell
330Figure 6. Changes in CD47 Amount, Distribution, and Signaling Capacity during Apoptosis
Error bars are ±SD. *p < 0.05 versus control.
(A–C) Viable and apoptotic cells were stained for surface CD47 and examined by flow cytometry. CD47 levels were found to be lower on
apoptotic fibroblasts and neutrophils (A and B) but not Jurkat T cells (C).
(D) On the other hand, during apoptosis of Jurkat T cells (and in fact of all the cell types examined), CD47 was found to distribute into patches
(stained green).
(E) Calreticulin (red) and CD47 (green) were seen to segregate away from each other on apoptotic cells.
(F) Viable but not apoptotic cells stimulated SIRPα phosphorylation in macrophages. J774 macrophages were stimulated with a CD47-Fc
ligand as control as well as viable or apoptotic Jurkat T cells for 30 min before examination of SIRPα phosphorylation. Additionally, macro-
phages were stimulated with viable neutrophils for various times.
(G) Inhibitors of the tyrosine phosphatase SHP-1 blocked the “don’t eat me” pathways and allowed uptake of viable neutrophils. Protein
tyrosine phosphatase inhibitor I (42 M), a SHP-1-specific inhibitor, or protein tyrosine phosphatase inhibitor IV (10 M), a control inhibitor,
was incubated with the macrophages for 20 min prior to the addition of target cells.
(H) Activation of the “don’t eat me” signaling by stimulation of macrophage SIRPα with a CD47-Fc construct or a rat Fc control for 20 min
prior to washing and addition of apoptotic neutrophils prevented their uptake.and P.-A.O., unpublished data). Thus, CD47 does not
seem to be required for apoptotic-cell removal but may
enhance uptake by serum factors that may act as
bridges or perhaps block CD47 signaling to SIRPα.
An implication of the loss of “don’t eat me” signals
during apoptosis is that, if they are deliberately blocked,
viable cells may now be recognized and ingested
through calreticulin effects even if they do not expose
PS. In fact, since PS often becomes exposed during
cell activation (Callahan et al., 2000; Frasch et al.,
2004), a normal inhibitory “don’t eat me” signal may
be important, and its loss, therefore, may contribute to
combined PS- and calreticulin-mediated engulfment.
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e” signal, but it should be noted that CD47-deficient
ice are viable even though they exhibit abnormal cell
emoval in vivo, are lymphatopenic, and show defects
n host defense (Lindberg et al., 1996). Given the pre-
umed importance of preventing casual removal of via-
le cells, we suggest the existence of additional “don’t
at me” signals that act in a compensatory role in
D47−/− mice. Supporting this theory, wild-type or
D47−/− T cells and bone-marrow cells were infused
nto irradiated immunodeficient recipients, and bone-
arrow transfers of CD47−/− T cells were unable to en-
raft or reconstitute wild-type recipients (Blazar et al.,
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331Figure 7. Calreticulin Associates with PS on Apoptotic Cells
Error bars are ±SD.
(A) Apoptotic CRT−/− and CRT+/+ MEFs did not show differences in PS exposure as assessed by binding of annexin V.
(B) Calreticulin and phosphatidylserine colocalized on the surface during apoptosis. Apoptotic neutrophils were stained for calreticulin (red)
or phosphatidylserine using factor Va and an anti-factor Va antibody (green).
(C) Phosphatidylserine and calreticulin localized to GM-1-positive sites. Apoptotic neutrophils were labeled with cholera toxin B (green) and
then stained for calreticulin or phosphatidylserine (red).
(D) Apoptotic undifferentiated PLB-985 cells (which do not expose PS and are poorly ingested) were rendered capable of being engulfed
after pretreatment with Fab#2 anti-CD47 to block their “don’t eat me” signals.
(E) Undifferentiated PLB-985 cells exhibited normal upregulation and redistribution of calreticulin as they became apoptotic.
(F) Undifferentiated PLB-985 cells did not redistribute or lose CD47 during apoptosis. Differentiated PLB-985 cells exhibited decreased
surface CD47 during apoptosis.
(G) A cartoon representation of surface changes that occur as a cell becomes apoptotic. Although viable-cell calreticulin may engage LRP
on the efferocyte cell surface, the CD47-SIRPα signaling pathway inhibits engulfment. Following apoptosis, calreticulin is upregulated and
patches to better stimulate LRP on the efferocyte. PS is also exposed at this point, and the SIRPα-CD47 signaling system is rendered inef-
fective.2001), i.e., wild-type splenic dendritic cells and macro-
phages removed almost all of the CD47-deficient cells
within 1 day of infusion. Alternatively, CD47−/− BM was
able to rescue CD47−/− but not CD47+/+ recipients, indi-
cating that the phagocytes in the CD47-deficient mouse
could not recognize and remove the CD47−/− cells. It
seems likely that there is significant redundancy in
“don’t eat me” ligands and signaling pathways that
have not yet been fully explored.
The observations described herein raise two addi-
tional points. Much emphasis has been placed on re-
distribution of potential ligands on the apoptotic-cellsurface that may be involved in stimulating or inhibiting
apoptotic-cell engulfment. We believe this to be a criti-
cal process in determining the stimuli that apoptotic
cells deliver to the efferocyte and the ultimate fate of
the apoptotic cells. The mechanisms that mediate this
redistribution are at present unknown, although we
have suggested a possible connection between altered
phospholipid asymmetry and the loss, redistribution, or
inactivation of CD47 seen on apoptotic cells. In addi-
tion, the finding that viable cells are readily ingested if
“don’t eat me” signals are disrupted raises the intrigu-
ing and challenging possibility that recognition and re-
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332moval by efferocytosis is a default process in multicel-
lular organisms that is actively prevented by inhibitory
ligands on viable cells.
Experimental Procedures
Reagents
Lucifer yellow and antibody were obtained from Molecular Probes
(Eugene, Oregon). Calreticulin from either bovine liver (90% purity,
Sigma, St. Louis) or recombinant GST-fusion proteins was ex-
pressed and purified as described (Orr et al., 2003a). Native purified
calreticulin as well as recombinant proteins bind calcium at levels
found in tissue culture media. Hsp90 (MBL International, Woburn,
Massachusetts) and calreticulin were used at 1 g/ml, and RAP
(Research Diagnostics Inc., Flanders, New Jersey) was used at an
inhibitory concentration of 250 nM. Anti-N-terminal calreticulin (Af-
finity Bioreagents Inc., Golden, Colorado) was used at 1 g/ml.
Anti-active caspase 3 (Cell Signaling Technology, Beverly, Mas-
sachusetts) was used at 1:50, and FITC-conjugated F4-80 (Caltag,
San Diego, California) was used at 1:100. Anti-CD47 monoclonal
antibody (mAb B6H12; IgG1) was purified from hybridoma superna-
tants by ammonium-sulfate precipitation and protein G chromatog-
raphy using HiTrap columns (Amersham Biosciences, Piscataway,
New Jersey). Phi Phi Lux was used according to the manufacturer’s
recommendations (Calbiochem, San Diego, California). An LRP li-
gand-blocking antibody or control cytoplasmic antibody (a gener-
ous gift from Dr. Dudley Strickland, the University of Maryland Hos-
pital) was used at 50 g/ml.
Cell Culture and Induction of Apoptosis
See Supplemental Data.
Stimulation of Macropinocytosis
Macrophages were stimulated with calreticulin or Hsp90, CD47−/−
or wild-type erythrocytes, and/or leukocytes in the presence of luc-
ifer yellow. Cells were washed, fixed, and permeabilized with 0.1%
Triton-X for 15 min and incubated with a 1:500 dilution of anti-
lucifer-yellow antibody, washed, and counterstained with FITC anti-
rabbit IgG antibody.
Phagocytosis Assays
Phagocytosis assays were performed as previously described
(Hoffmann et al., 2001). In some experiments, viable human neutro-
phils were coated with Fab#2 monoclonal antibody against CD47 (2
g/ml) (Fab#2 fragments of mAb B6H12 were obtained by pepsin
digestion and removal of remaining Fc fragments by protein A chro-
matography) or an isotype control for 30 min prior to washing and
feeding to macrophages. Alternatively, the macrophages were pre-
treated with 2 g/ml of anti-SIRPα antibody (anti-SIRPα, P84) or
isotype control for 30 min and washed before addition of viable
human neutrophils. Amiloride (Sigma) was added at 3 mM in se-
rum-free DMEM for 15 min prior to the addition of target cells.
SHP-1 inhibition experiments were performed with J774 macro-
phages pretreated with 45 M protein tyrosine phosphatase inhibi-
tor I or 10 M phosphatase inhibitor IV (Calbiochem), a SHP-2 and
PTP protein tyrosine phosphatase inhibitor, prior to the addition of
viable neutrophils. MEFs were plated at 5 × 105 for 24 hr prior to
addition of targets. CRT−/− MEFs were coated with calreticulin or
Hsp90 on ice for 30 min and washed twice prior to addition to
phagocytes. CD47-wild-type and -deficient erythrocytes were
added to macrophages or fibroblasts at a ratio of 15:1, incubated
for 90 min, and assayed as previously described (Vandivier et al.,
2002). Treatment of targets with an anti-calreticulin (2 g/ml) or
control antibody for 30 min at 4°C was followed by washing. For
stimulated phagocytosis assays (bystander uptake, Hoffmann et
al., 2001), J774 macrophages were plated in 24-well plates at 5 ×
104 cells/well for 2 days. Viable neutrophils were allowed to adhere
for 20 min prior to stimulation with calreticulin or Hsp90. In all
cases, uptake of targets was measured as described (Fadok et al.,
1993). The inherent variability of professional and nonprofessional
phagocytes in ingesting apoptotic cells lends to the differences
observed in the phagocytic indexes.
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curface Modulation Experiments
hese were performed as described (Ogden et al., 2001) with 1%
SA (Pharmacia, Sweden), 1 g/ml or 10 g/ml mouse anti-human
D91 (α chain) monoclonal antibody (BioMac, Leipzig, Germany),
r control antibody (Santa Cruz Biotech, Heidelberg, Germany).
ideomicroscopy
774 macrophages were cultured on Delta T dishes (Bioptechs) for
days and washed before addition of apoptotic target MEFs at a
atio of 10:1. After 30 min on a 37°C heated stage, they were ana-
yzed using a 60× oil objective on an Olympus IX70 microscope.
ictures were recorded every 15 s for 30 min using Tillvision soft-
are. Anti-SIRPα antibody (1 g/ml) or control was added 30 min
efore viable targets.
urface Staining
ells were washed twice and transferred to 4°C in PBS containing
.5% serum and 2% BSA. Antibodies or controls were added at 1
g/ml for 1 hr before washing and fixation (4% paraformaldehyde
nd 3% sucrose). A second antibody at 1:100 was added for an
dditional 30 min on ice before washing and prepared for flow cyto-
etry or microscopy. For GM-1 (5.0 g/ml, Sigma) staining, cells
ere treated with cholera toxin B for 15 min on ice prior to antibody
ddition. Anti-factor Va experiments were performed according to
rasch et al. (2004). Microscope images were collected with Slide-
ook software (Intelligent Imaging Innovation [3I], Denver) on a
eica DMRXA microscope at 62× magnification. Scale bars are all
qual to 5 m. All microscopy samples were processed with the
ppropriate isotype control, and these were demonstrated to have
o significant staining. Examples of this can be seen for CD47 and
alreticulin in the flow experiments in Figures 1D, 2F, and 6A–6C
nd Figure S14.
ac Activity Assay
ac activity assays were performed as per the manufacturer’s in-
tructions (Upstate Biotechnology). In short, 10 million J774 macro-
hages were plated for 2 days and stimulated with calreticulin for
0 min or RAP for 20 min prior to calreticulin stimulation. Samples
ere lysed and active Rac was isolated using Sepharose bound
ak. Lysates were incubated for 45 min, washed, boiled, and run
n a 12% SDS-PAGE gel.
IRP Phosphorylation
774 macrophages were plated at 5 × 105 for 2 days before addi-
ion of targets. Cells were washed, lysed, and SIPRα immunopreci-
itated (Upstate Biotechnology). Samples were run on a 7% gel
nd probed with an anti-phosphotyrosine antibody (4G10, Upstate
iotechnology). To ensure equal loading, the membrane was stripped
nd reprobed with an anti-SIRPα antibody.
mbryo Processing
ay 13.5 embryos were harvested from heterozygote mating and
yped via Western blot. Embryos were fixed in 4% paraformalde-
yde overnight, frozen in OTC, and stored at −80°C. Sequential
ections were stained for active caspase 3 according to manufac-
urer’s specifications and were washed twice, and a Cy3 secondary
t 1:500 dilution was added along with FITC-conjugated anti-F4-80
ntibody. Sections were incubated for 1 hr at 4°C, washed,
ounted with OPDA containing a 1:1000 dilution of DAPI, and visu-
lized on a Leica DMRXA microscope using Slidebook software.
uantification of apoptotic cells was performed using at least ten
andom high-power fields from five different slides and multiple
mbryo samples.
n Vivo Experiments
n vivo apoptotic-cell clearance was performed as described (Stu-
rt et al., 2005). The peritoneums were lavaged 60 min after instilla-
ion of the apoptotic cells. Total cell counts were made for each
ouse. A cytospin slide of lavaged cells was stained with modified
right’s Giemsa (Leukostat; Fisher) and evaluated for macrophage
hagocytosis of apoptotic cells and the total number of apoptotic
ells recovered.
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333Statistics
All experiments were performed at least three times. Statistical
analysis and p values were carried out using the JMP statistical
program (SAS Institute, Cary, North Carolina). The Tukey-Kramer
and Dunnett’s parametrical tests were used for single and multiple
comparisons, respectively.
Supplemental Data
Supplemental Data include Supplemental Experimental Pro-
cedures, Supplemental References, 14 figures, and 4 movies and
can be found with this article online at http://www.cell.com/cgi/
content/full/123/2/321/DC1/.
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